Company: LNAI
Filing Date: 2025-12-03
Form Type: 424B5
Source: 0001731122-25-001626
Chunk: 32

Company: Lunai Bioworks Inc.
Filing Date: 2025-12-03
Form: 424B5
Chunk 32
---
. This prospectus describes the general manner in which our securities may be offered
by this prospectus. Each time we sell securities, we will provide a prospectus supplement that will contain specific information about
the terms of that offering. The prospectus supplement may also add, update or change information contained in this prospectus or in documents
incorporated by reference in this prospectus. The prospectus supplement that contains specific information about the terms of the securities
being offered may also include a discussion of certain U.S. Federal income tax consequences and any risk factors or other special considerations
applicable to those securities. To the extent that any statement that we make in a prospectus supplement is inconsistent with statements
made in this prospectus or in documents incorporated by reference in this prospectus, you should rely on the information in the prospectus
supplement.

You should not assume that the
information contained in this prospectus, any applicable prospectus supplement or any related free writing prospectus is accurate on any
date subsequent to the date set forth on the front of the document or that any information we have incorporated by reference is correct
on any date subsequent to the date of the document incorporated by reference, even though this prospectus, any applicable prospectus supplement
or any related free writing prospectus is delivered, or securities are sold, on a later date. You should carefully read both this prospectus
and any prospectus supplement together with the additional information described under “Where You Can Find More Information”
before buying any securities in this offering.

The terms “Renovaro”,
the “Company,” “we,” “our,” or “us,” in this prospectus refer to Renovaro Inc. and its
wholly-owned subsidiaries, unless the context suggests otherwise.

<div align='center'>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</div>

Some of the statements made under
“Prospectus Summary,” “Use of Proceeds,” and elsewhere in this prospectus, as well as the documents incorporated
by reference herein, including in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024, constitute forward-looking statements
within the meaning of The Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements
by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,”
“believes,” “estimates,” “predicts,” “potential,”